内皮细胞培养步骤(总结,)(6)

protein (PrP) gene in sheep. Nat Biotechnol, 2001, 19559-562.

:

**20. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science, 2002, 295(5557): 1089-1092.

** 21. Aoki N. Breakthrough in cloning claimed. Boston Globe， 2002，Aug.23.

22. Tanemura M, Yin D, Chong AS, et al. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest, 2000, 105(3): 301-310.

23. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet, 1994, 344(8934): 1402-1404.

24. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation, 2000, 69(11): 2296-2304. 25. Delikouras A, Hayes M, Malde P, et al. Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations

of xenoreactive natural antibody. Transplantation, 2001, 71(5): 599-605.

26. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today, 1990, 11(12): 450-456.

27. Bach FH, Turman MA, Vercellotti GM, et al. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc, 1991, 23(1 Pt 1): 205-207.

28. Cooper DK. Is xenotransplantation a realistic clinical option? Transplant Proc, 1992, 24

: 2393-2396.

*29. Saadi S, Takahashi T, Nagayasu T, et al. The role of cytokines in rejection of discordant xenotransplants. Transplant Proc, 1999, 31(1-2): 911-912.

*30. Carrington CA, dos Santos Cruz G. Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition. Xenotransplantation, 2001, 8(2): 100-105.

*31. Fecke W, Long J, Richards A, Harrison R. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.

Xenotransplantation, 2002, 9(2): 97-105.

**32. Adams DH, Kadner A, Chen RH, Farivar RS. Human membrane cofactor protein (MCP,CD46) protects transgenic pig

hearts

from

hyperacute

rejection

in

primates.

Xenotransplantation, 2001, 8(1): 36-40.

33. Niemann H, Verhoeyen E, Wonigeit K, et al. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against Hyperacute rejection. Transplantation, 2001, 72(12): 1898-1906.

34. Diamond LE, Quinn CM, Martin MJ, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation, 2001, 71(1): 132-142. 35. Cowan PJ, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause

coagulopathy

in

non-immunosuppressed

baboons.Transplantation, 2000, 69(12):2504-2515. **36.

Shiraishi

M,

Oshiro

T,

Nozato

E,

et

al.

Adenovirus-mediated gene transfer of triple human complement regulating proteins(DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation modelPart II: xenogeneic perfusion of the porcine liver in vivo. Transpl Int, 2002,15(5): 212-219.

*37. Robson SC, Cooper DK, d’Apice AJ. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation, 2000, 7(3): 166-176. *38. Bach FH. Genetic engineering as an approach to xenotransplantation. World J Surg, 1997, 21(9): 913-916. *39. Fecke W, Long J, Richards A, Harrison R. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex. Xenotransplantation, 2002, 9(2): 97-105.

40. Bustos M, Saadi S, Platt JL. Platelet-mediated activation of endothelial cells: Implications for the pathogenesis of transplant rejection. Transplantation, 2001, 72: 509-515. *41.Xu H, Arnaud F, Tadaki DK, et al. Human platelets activate porcine endothelial cells through a CD154-dependent pathway. Transplantation, 2001, 72(11): 1858-1861.

*42.Chen D, Riesbeck K, McVey JH, et al. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation, 2001, 8(4): 258-265.

43. Henn V, Steinbach S, Buchner K, et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood,

2001, 98(4): 1047-1054.

44. Rushworth SA, Bravery CA, Thompson S. Human CD154 induces activation of porcine endothelial cells and up-regulation of MHC class II expression. Transplantation, 2001, 72(1): 127-132.

45. Alwayn IP, Buhler L, Appel JZ 3rd, et al. Mechanisms of thrombotic

microangiopathy

following

xenogeneic

hematopoietic progenitor cell transplantation. Transplantation, 2001, 71(11): 1601-1609.

*46. Appel JZ 3rd, Newman D, Awwad M, et al. Activation of human endothelial cells by mobilized porcine leukocytes in vitro. Transplantation, 2002, 73

: 1302-1309.

47. Kalady MF, Lawson JH, Sorrell RD, et al. Decreased fibrinolytic activity in porcine

-to- primate cardiac

xenotransplantation. Mol Med, 1998, 4(9): 629-637.

**48. Dorling A, Lechler R. Disordered thromboregulation after xenografting. Current Opinion in Organ Transplantation, 2001, 6: 36-41.

49. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant, 2002, 2

: 520-525.

**50. Holgersson J, Ehrnfelt C, Hauzenberger E, et al. Leukocyte

百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，免费范文网，提供经典小说综合文库内皮细胞培养步骤(总结,)(6)在线全文阅读。